Collectively, these data revealed that syndapin-2 levels are affected in healthy ageing and Alzheimer’s disease, which then may trigger LRP1/Aβ trafficking through the vesicular endosomal pathway. This evidence concerns the gene LRP1 and early-onset autosomal dominant Alzheimer disease.